Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Advances in Experimental Medicine and Biology|March 12, 2015
C peptides as entry inhibitors for gene therapyLisa Egerer, Hans-Peter Kiem, Dorothee von LaerJournal of Virology|March 13, 2009
Mutations in gp120 contribute to the resistance of human immunodeficiency virus type 1 to membrane-anchored C-peptide maC46Felix G Hermann, Lisa Egerer, Frances Brauer, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|March 3, 2011
Secreted antiviral entry inhibitory (SAVE) peptides for gene therapy of HIV infectionLisa Egerer, Andreas Volk, Joerg Kahle, et al.Antimicrobial Agents and Chemotherapy|November 14, 2012
A rationally engineered anti-HIV peptide fusion inhibitor with greatly reduced immunogenicityFrances Brauer, Kerstin Schmidt, Roland C Zahn, et al.Journal of Virology|February 21, 2014
VSV-GP: a potent viral vaccine vector that boosts the immune response upon repeated applicationsReinhard Tober, Zoltan Banki, Lisa Egerer, et al.Molecular Therapy Oncolytics|October 15, 2016
Application of interferon modulators to overcome partial resistance of human ovarian cancers to VSV-GP oncolytic viral therapyCatherine Dold, Carles Rodriguez Urbiola, Guido Wollmann, et al.Pageof 1